Literature DB >> 3123103

Ultrasensitive assay of thyroid stimulating hormone in patients with acute non-thyroidal illness.

J M Boles1, J F Morin, M A Garre.   

Abstract

Serum TSH in critically ill euthyroid patients is generally within the normal range when measured with conventional radioimmunoassays. Sensitive immunoradiometric assays allow detection of low levels of serum TSH. We assessed this method in a prospective study of 34 euthyroid patients admitted to our critical care unit. Serum TSH ranged from 0.12 to 3.60 mU/l and was significantly lower for the whole group than in the controls (P less than 0.001), as also were serum total T4 and T3 values (P less than 0.001). However, 21 patients had a serum TSH within the normal range (group 1) and 13 patients (33%) had a serum TSH less than 0.40 mU/l (group 2). The two groups did not differ in age, sex, type and severity of illness, outcome, and serum T4 and T3 levels. However, the magnitude of TSH increase from the baseline value after the i.v. injection of 200 micrograms of TRH, assessed by the 30 min TSH/basal TSH ratio was significantly higher in group 2 (P less than 0.05). These results suggest that a substantial proportion of patients with acute illness have a clearly low serum TSH, unaccounted for by age, sex, type or quantified severity of illness, serum T4 and T3 levels. In addition, the secretory capacity of the pituitary to exogeneous TRH is significantly enhanced in those patients with low basal TSH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123103     DOI: 10.1111/j.1365-2265.1987.tb01166.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Thyroid function testing.

Authors:  T J McKenna; D Igoe
Journal:  Ir J Med Sci       Date:  1988-12       Impact factor: 1.568

2.  Serum thyroxine and thyrotropin concentrations decrease with severity of nonthyroidal illness in cats and predict 30-day survival outcome.

Authors:  Mark E Peterson; Danielle L Davignon; Nicole Shaw; Eric Dougherty; Mark Rishniw; John F Randolph
Journal:  J Vet Intern Med       Date:  2020-10-01       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.